Skip to main content

Table 1 Inclusion and exclusion criteria of the patients

From: The effects of adjunctive treatment with l-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial

Eligibility criteria

Inclusion criteria

Critically illness

Exclusion criteria

Renal or liver disease

Age > 18 y

Dialysis

Estimated that stay in ICU longer than 2–3 days

Chemotherapy

Patients with underlying diseases: CVD, CNS, COPD, gastrointestinal diseases, diabetes, stroke, and cancer

Pregnancy or lactation

Any nutritional supplement use

  1. ICU intensive care unit, CVD cardiovascular diseases, CNS central nervous system, COPD chronic obstructive pulmonary disease
Back to article page

Trials

ISSN: 1745-6215